X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. AUROBINDO PHARMA FDC LTD./
AUROBINDO PHARMA
 
P/E (TTM) x 23.0 19.2 119.5% View Chart
P/BV x 5.2 4.8 106.8% View Chart
Dividend Yield % 0.9 0.3 283.8%  

Financials

 FDC LTD.   AUROBINDO PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
AUROBINDO PHARMA
Mar-17
FDC LTD./
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs144895 16.0%   
Low Rs79622 12.7%   
Sales per share (Unadj.) Rs47.6254.6 18.7%  
Earnings per share (Unadj.) Rs7.639.3 19.4%  
Cash flow per share (Unadj.) Rs9.046.6 19.3%  
Dividends per share (Unadj.) Rs2.252.50 90.0%  
Dividend yield (eoy) %2.00.3 613.6%  
Book value per share (Unadj.) Rs47.5160.0 29.7%  
Shares outstanding (eoy) m177.83585.88 30.4%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x2.33.0 78.5%   
Avg P/E ratio x14.619.3 75.7%  
P/CF ratio (eoy) x12.316.3 75.8%  
Price / Book Value ratio x2.34.7 49.4%  
Dividend payout %29.66.4 464.6%   
Avg Mkt Cap Rs m19,784444,390 4.5%   
No. of employees `000NA14.0 0.0%   
Total wages/salary Rs m1,22117,678 6.9%   
Avg. sales/employee Rs ThNM10,667.8-  
Avg. wages/employee Rs ThNM1,264.3-  
Avg. net profit/employee Rs ThNM1,645.8-  
INCOME DATA
Net Sales Rs m8,459149,157 5.7%  
Other income Rs m3941,159 34.0%   
Total revenues Rs m8,852150,316 5.9%   
Gross profit Rs m2,07034,343 6.0%  
Depreciation Rs m2494,276 5.8%   
Interest Rs m31667 4.6%   
Profit before tax Rs m2,18430,558 7.1%   
Minority Interest Rs m050 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6067,597 8.0%   
Profit after tax Rs m1,35323,012 5.9%  
Gross profit margin %24.523.0 106.3%  
Effective tax rate %27.724.9 111.6%   
Net profit margin %16.015.4 103.7%  
BALANCE SHEET DATA
Current assets Rs m4,35592,062 4.7%   
Current liabilities Rs m1,79266,223 2.7%   
Net working cap to sales %30.317.3 174.9%  
Current ratio x2.41.4 174.8%  
Inventory Days Days44106 41.9%  
Debtors Days Days2568 36.4%  
Net fixed assets Rs m3,02562,919 4.8%   
Share capital Rs m179586 30.5%   
"Free" reserves Rs m8,24393,133 8.9%   
Net worth Rs m8,45393,719 9.0%   
Long term debt Rs m111,814 0.6%   
Total assets Rs m10,557162,494 6.5%  
Interest coverage x71.446.8 152.6%   
Debt to equity ratio x00 6.5%  
Sales to assets ratio x0.80.9 87.3%   
Return on assets %13.114.6 90.0%  
Return on equity %16.024.6 65.2%  
Return on capital %23.532.7 71.8%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14675,838 1.5%   
Fx outflow Rs m35530,224 1.2%   
Net fx Rs m79145,613 1.7%   
CASH FLOW
From Operations Rs m1,48532,786 4.5%  
From Investments Rs m-620-17,870 3.5%  
From Financial Activity Rs m-753-19,153 3.9%  
Net Cashflow Rs m113-4,239 -2.7%  

Share Holding

Indian Promoters % 68.9 54.1 127.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 8.0 59.1%  
FIIs % 7.5 27.7 27.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 10.2 186.3%  
Shareholders   23,730 69,601 34.1%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   CADILA HEALTHCARE  J.B.CHEMICALS  MERCK LTD  DISHMAN PHARMA  FULFORD INDIA  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Healthcare & Metal Stocks Gain(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1.5% while the Hang Seng is up 1.2%.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 12.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, AUROBINDO PHARMA has posted a net profit of Rs 5 bn (down 12.0% YoY). Sales on the other hand came in at Rs 43 bn (up 15.5% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 19, 2018 11:25 AM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - ALEMBIC PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS